NPF Early Career Research Grant recipient Holly Anderton chats about how she became a research scientist and what drives her in her study of psoriatic disease.

Recent posts

image of foam with the words "FDA approved"
Lexette, a topical corticosteroid foam, aims to reduce plaques.
FDA Approved Topical
The latest topical lotion aims to reduce plaque and clear your skin.
FDA Approval Skyrizi
The latest interleukin-23 inhibitor is aimed at adults with moderate-to-severe...
Jawbone, chatter teeth
Candace Primack experienced mysterious jaw pain during graduate school. Fifteen...
Don’t turn taking your meds into an uphill battle. Get the facts and stay the...
The first two AAD-NPF guidelines in a series of six tackle biologics and...
Allison Truong and Kristina Callis Duffin
Our boot camp for rookie physicians marks 20 years of strengthening skills and...
A Utah woman demands to see the best dermatologist around – and gets a second...
cartoon of people studying giant book
NPF and the American College of Rheumatology release a pioneering treatment...